A detailed history of Abound Wealth Management transactions in Haleon PLC stock. As of the latest transaction made, Abound Wealth Management holds 91 shares of HLN stock, worth $869. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91
Previous 91 -0.0%
Holding current value
$869
Previous $752,000 28.06%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$8.01 - $8.64 $2,362 - $2,548
-295 Reduced 76.42%
91 $752,000
Q1 2024

Aug 08, 2024

BUY
$8.02 - $8.67 $2,365 - $2,557
295 Added 324.18%
386 $3.28 Million
Q4 2023

Aug 08, 2024

SELL
$7.78 - $8.62 $715 - $793
-92 Reduced 50.27%
91 $749,000
Q3 2023

Aug 08, 2024

BUY
$7.85 - $8.94 $808 - $920
103 Added 128.75%
183 $1.53 Million
Q2 2023

Aug 08, 2024

BUY
$8.04 - $9.0 $643 - $720
80 New
80 $671,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.1B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.